Popular diabetes and obesity drugs also protect kidneys, study shows 0 26.11.2024 03:50 Sciencedaily.com The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
